How Targeted Therapy Achieves Responses Across Multiple Canc

Erdafitinib is the first approved FGFR-targeted treatment for advanced urothelial cancer, reveal scientists.

Related Keywords

, Penn Dental , Penn Engineering , Urothelial Cancer , Multiple Tumor , Clinical Trial ,